ALLERGY TREATMENT MARKET

• Based on a report from Transparency Market Research, the North American allergy treatment market revenue is $9.706 billion in 2017.
• The global market revenue is expected to grow at a rate of 5.5% from 2017 to 2025.
• The worsening air pollution condition is seen to increase the demand for allergy treatment drugs.
• However, the preference for more traditional medicines is expected to dampen market growth.
•  Various side effects that are associated with allergy treatment drugs can also slow down the demand for these products.
• The common types of allergy medications are antihistamines, decongestants, corticosteroids, mast cell stabilizers, leukotriene inhibitors, allergen immunotherapy, and emergency epinephrine shots.
• These products can come in the form of "pills, liquids, inhalers, nasal sprays, eye drops, skin creams, or shots."
• Some of the products can be bought over-the-counter while others need prescriptions first.
• Antihistamines reduce the concentration of the histamine chemical.
• This chemical is a by-product of the body's immune system when reacting to allergy symptoms.
• Oral antihistamines can be typically bought over-the-counter or through prescription.
• Some of the generic and brand names of antihistamine medications are cetirizine (Zyrtec Allergy); desloratadine (Clarinex); fexofenadine (Allegra Allergy); levocetirizine (Xyzal); and loratadine (Alavert, Claritin).
• Antihistamines can also be administered through nasal sprays.
• Some of the generic and branded antihistamine nasal sprays include azelastine (Astelin, Astepro) and olopatadine (Patanase).
•  Allegra provides its brand of fexofenadine antihistamine products to treat allergy symptoms such as itching and hives.
•  Bayer's Claritin provides various forms of products to treat allergy symptoms.

PROPRIETARY RESEARCH AVAILABLE

•  Global Markets for Allergy Diagnostics and Treatment ( BCC Research, $5,500)
• Global Market for Allergy Products ($337.86)
• Company Profiles ($4,427.50)